Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants

Trimeric protein vaccine based on Beta variant elicits robust immune response against BA.4/5-included SARS-CoV-2 Omicron variants

Abstract The current Coronavirus Disease 2019 (COVID-19) pandemic, induced by newly emerging severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron variants, posed great threats to global public health security. There is an urgent need to design effective next‑generation vaccines again...

Full description

Bibliographic Details
Main Authors: Cai He, Li Chen, Jingyun Yang, Zimin Chen, Hong Lei, Weiqi Hong, Xiangrong Song, Li Yang, Jiong Li, Wei Wang, Guobo Shen, Guangwen Lu, Xiawei Wei
Format: Article
Language:English
Published: Springer 2023-03-01
Series:Molecular Biomedicine
Subjects:
RBD
Vaccine
Immune response
SARS-CoV-2
Omicron
Variants
Online Access:https://doi.org/10.1186/s43556-023-00121-7

Internet

https://doi.org/10.1186/s43556-023-00121-7

Similar Items